+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients

Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients

Clinical Nephrology 58(5): 363-369

Background: The diagnosis of iron deficiency using the current commonly used tests is usually difficult in hemodialysis patients. Soluble transferrin receptor (sTfR) has caught the attention of physicians recently as regards its use as a parameter for the evaluation of iron status.

(PDF emailed within 1 workday: $29.90)

Accession: 003932038

Download citation: RISBibTeXText

PMID: 12425487

Related references

A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients. Nephron 92(1): 32-35, 2002

Assessment of erythropoiesis suppression in patients on chronic blood transfusions Value of serum transferrin receptor, erythropoietin and reticulocytes. Pediatric Research 43(4 PART 2): 139A, April, 1998

Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis. Nihon Jinzo Gakkai Shi 44(5): 453-463, 2002

Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients. Pathology 39(3): 349-353, 2007

Serum erythropoietin and transferrin receptor levels rise during iron deficient erythropoiesis. Experimental Hematology (Charlottesville) 19(6): 484, 1991

Serum soluble interleukin 2 receptor in hemodialysis patients treated with recombinant human erythropoietin. Blood Purification 13(6): 347-356, 1995

Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes. Haematologica 79(6): 493-499, 1994

Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin. Zhonghua Yi Xue Za Zhi 61(8): 456-462, 1998

Soluble transferrin receptor as a marker of erythropoiesis in patients undergoing high-flux hemodialysis. Bosnian Journal of Basic Medical Sciences, 2017

The soluble transferrin receptor concentration reflects the iron status in dialysis patients. Kidney & Blood Pressure Research 23(3-5): 315-316, 2000

Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine. Clinical Nephrology 36(3): 157-158, 1991

Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency. Medicina 61(5 Pt 1): 552-556, 2001

Similar serum transferrin receptor in preterm compared with term newborns Fetal erythropoiesis is maintained in preterms despite limited iron availability. Pediatric Research 53(4 Part 2): 405A, April, 2003

Regulation of soluble transferrin receptor concentrations in hemodialysis patients receiving recombinant erythropoietin. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 270A, Sept, 1999

Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Annals of Internal Medicine 72(6): 913-918, 1970